SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030053
Filing Date
2019-08-07
Accepted
2019-08-07 16:07:18
Documents
58
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pti-10q_20190630.htm 10-Q 2361534
2 EX-31.1 pti-ex311_7.htm EX-31.1 12053
3 EX-31.2 pti-ex312_8.htm EX-31.2 11990
4 EX-32.1 pti-ex321_6.htm EX-32.1 13225
  Complete submission text file 0001564590-19-030053.txt   6805648

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pti-20190630.xml EX-101.INS 1404743
6 XBRL TAXONOMY EXTENSION SCHEMA pti-20190630.xsd EX-101.SCH 37147
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pti-20190630_cal.xml EX-101.CAL 44955
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pti-20190630_def.xml EX-101.DEF 120745
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pti-20190630_lab.xml EX-101.LAB 344109
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pti-20190630_pre.xml EX-101.PRE 249828
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-37695 | Film No.: 191005497
SIC: 2834 Pharmaceutical Preparations